Loading...

IMRX - Immuneering Corporation

Analyst Downgrade Signal for 03-15-2024
Analyst Downgrade Signal: IMRX from Buy to Hold by Jefferies
Price Target: $16>>3


Loading Chart IMRX

Stock Signal Information


Signal

Analyst Downgrade Signal: IMRX from Buy to Hold by Jefferies
Price Target: $16>>3
Report Date: 03-15-2024
Symbol: IMRX - Immuneering Corporation
Sector: Healthcare
Industry: Biotechnology
Analyst Downgrade Signal: IMRX from Buy to Hold by Jefferies
Price Target: $16>>3

  IMRX Technical Analysis

Company Contact

Immuneering Corporation (IMRX)
245 Main Street
Cambridge, MA
Phone: 617 500 8080
Website: http://www.immuneering.com
CEO:

IMRX, Immuneering Corporation

IMRX Immuneering Corporation Logo Image

NASDAQ, Nasdaq Global Market


Company Profile

Immuneering Corporation provides genetic, genomic, and proteomic data analysis services for pharmaceutical companies to generate biological insights that enhance the clinical and commercial success of medicines. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.